Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine and Pregabalin for Prevention of Chronic Postsurgical Pain in Spinal Tumor Surgery
NCT06117917Phase 3Unknown
- Sponsor
- Beijing Tiantan Hospital
- Start
- Nov 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic postsurgical pain (CPSP) comparing S-ketamine and pregabalin with Placebo (2 arms). Primary endpoint: Proportion of patients with chronic postsurgical pain at 3 months. Status: unknown.
02
Drugs
esketaminepregabalin
03
Conditions
chronic postsurgical pain (CPSP)
Beyond the preview
Go deeper on NCT06117917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06117917.